bLong Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$867K Buy
15,052
+510
+4% +$29.3K 0.56% 27
2026
Q1
$882K Sell
14,542
-200
-1% -$11.7K 0.67% 26
2025
Q4
$795K Hold
14,742
0.56% 28
2025
Q3
$665K Sell
14,742
-200
-1% -$9.34K 0.46% 33
2025
Q2
$692K Buy
14,942
+979
+7% +$48.1K 0.53% 34
2025
Q1
$852K Buy
13,963
+500
+4% +$29.1K 0.76% 28
2024
Q4
$761K Buy
+13,463
New +$752K 0.63% 30

Other funds holding BMY

bLong Financial's BMY Position: Q2 2026 in Review

bLong Financial increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, buying an estimated $29.3K and bringing the position to 15,052 shares worth $867K. The position accounts for 0.56% of the portfolio, ranked #27.

bLong Financial first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $882K in Q1 2026. 953 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • bLong Financial held 15,052 shares of Bristol-Myers Squibb worth $867K as of Q2 2026.
  • bLong Financial bought 510 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.3K.
  • Bristol-Myers Squibb made up 0.56% of bLong Financial's portfolio in Q2 2026, its #27 holding.
  • bLong Financial first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • bLong Financial's Bristol-Myers Squibb position peaked at $882K in Q1 2026.
  • 953 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on bLong Financial's 13F filing for Q2 2026, filed 21 Jul 2026.